Just coming down from Pluto [press] is this edited collection that promises to cover – with 30 different authors, all of whom will be hunted down and killed by big pharma assassins, no doubt – the “* current regulation of the industry * ethical issues in developing and distributing drugs * how it prices and markets drugs * recommendations on how to improve pharmaceutical policy * the importance of pharmaceuticals * the structure of the pharmaceutical industry * what drugs are needed on a worldwide scale.” Just make sure that if you work at Cleveland Clinic you order this to your home address and don’t buy it while you’re at work.
Udo Thinks About Drugs Again
Related posts
Moral and Practical Considerations in the Debate on Physician-Assisted Suicide: The Terminally Ill Adults (End of Life) Bill in the UK
A controversial Bill, titled Terminally Ill Adults (End of Life) Bill, was recently proposed in England. The primary aim of this Bill is to allow adults aged 18 and over who are terminally ill and have the mental capacity to request assistance from a doctor to end their lives. According to the Bill, a person […]
Guns, Insurance, and the Political Determinants of Health
In the United States, where gun controls are far too few and unchecked guns are generally okay, even celebrated, such political determinants of health have constantly terrible impacts. Guns have one purpose: to kill. Such political determinants of health have determined that anyone can be shot dead or injured with a gun at any point […]
Off the Shelf and into Practice—Maybe
In September, the World Health Organization (WHO) released new guidance on best practices for clinical trials. The 76-page guidance document, called for by a resolution adopted by the 2022 World Health Assembly, seeks to improve the design, conduct, and oversight of clinical trials globally. Building upon guidance from the Council of International Organizations of Medical […]
The Danger of Conflating the Russian Scientific Community with Putin’s Regime in Global Bioethics
The global bioweapons regime stands at a pivotal point where collaboration or conflict can determine the future of bioethical standards and international security. A recent sign pointing toward conflict is the North Atlantic Treaty Organization’s Biotechnology and Human Enhancement Technologies Strategy, which singles Russia as a bad actor. Such an approach not only risks […]